Skip to main content
Top
Published in: Acta Neuropathologica 5/2003

01-11-2003 | Regular Paper

Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis

Authors: Qin Miao, Wolfgang Baumgärtner, Klaus Failing, Susanne Alldinger

Published in: Acta Neuropathologica | Issue 5/2003

Login to get access

Abstract

Matrix metalloproteinases (MMPs) are zinc- and calcium-dependent enzymes that cleave molecules of the extracellular matrix, and thus are able to open the blood-brain-barrier and affect myelin. Their inhibitors (TIMPs) are important candidates for the therapy of demyelinating diseases. To establish an immunohistochemical profile of MMP and TIMP expression in plaque variants in dogs with spontaneous demyelinating distemper encephalitis, paraffin-embedded cerebella were studied employing the avidin-biotin-peroxidase complex method with a panel of nine polyclonal (anti-MMP-1, -3, -7, -9, -12, -13, -14, -TIMP-1, and -2) and two monoclonal antibodies (anti-latent MMP-2, and -MMP-11). All MMPs and TIMPs were prominently up-regulated in acute and subacute non-inflammatory lesions, and double-labeling techniques showed that they were mainly expressed by astrocytes and brain macrophages/microglia. In subacute inflammatory and chronic plaques, a moderate to strong decrease of MMP and TIMP expression compared to acute lesions was observed. In these phases MMP-11, -12, and -13 were still moderately present. In addition to astro- and microglia, invading perivascular mononuclear cells were positive for MMPs and TIMPs. In summary, there seems to be a phase-dependent expression of MMPs and TIMPs in demyelinating canine distemper encephalitis, and an MMP-TIMP imbalance might account for the lesion progression in this disease.
Literature
1.
go back to reference Alldinger S, Baumgärtner W, Örvell C (1993) Restricted expression of viral surface proteins in canine distemper encephalitis. Acta Neuropathol 85:635–645PubMed Alldinger S, Baumgärtner W, Örvell C (1993) Restricted expression of viral surface proteins in canine distemper encephalitis. Acta Neuropathol 85:635–645PubMed
2.
go back to reference Alldinger S, Wünschmann A, Baumgärtner W, Voss C, Kremmer E (1996) Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper virus encephalitis. Acta Neuropathol 92:273–280CrossRefPubMed Alldinger S, Wünschmann A, Baumgärtner W, Voss C, Kremmer E (1996) Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper virus encephalitis. Acta Neuropathol 92:273–280CrossRefPubMed
3.
go back to reference Alldinger S, Fonfara S, Kremmer E, Baumgärtner W (2000) Up-regulation of the hyaluronate receptor CD44 in canine distemper demyelinated plaques. Acta Neuropathol 99:138–146PubMed Alldinger S, Fonfara S, Kremmer E, Baumgärtner W (2000) Up-regulation of the hyaluronate receptor CD44 in canine distemper demyelinated plaques. Acta Neuropathol 99:138–146PubMed
4.
go back to reference Anthony DC, Miller KM, Fearn S, Townsend MJ, Opdenakker G, Wells GM, Clements JM, Chandler S, Gearing AJ, Perry VH (1998) Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol 87:62–72PubMed Anthony DC, Miller KM, Fearn S, Townsend MJ, Opdenakker G, Wells GM, Clements JM, Chandler S, Gearing AJ, Perry VH (1998) Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol 87:62–72PubMed
5.
go back to reference Bever CT, Rosenberg GA (1999) Matrix metalloproteinases in multiple sclerosis—Targets of therapy or markers of injury? Neurology 53:1380–1381PubMed Bever CT, Rosenberg GA (1999) Matrix metalloproteinases in multiple sclerosis—Targets of therapy or markers of injury? Neurology 53:1380–1381PubMed
6.
go back to reference Brew K, Dinakarpandian D, Nargase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283PubMed Brew K, Dinakarpandian D, Nargase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283PubMed
7.
go back to reference Black RA, Rauch CT, Kozlosky CJ, et al (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729–732PubMed Black RA, Rauch CT, Kozlosky CJ, et al (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729–732PubMed
8.
go back to reference Clements JM, Cossins JA, Wells GMA, Corkill DJ, Helfrich K, Wood LM, Pigott R, Stabler G, Ward GA, Gearing AJH, Miller KM (1997). Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor. J Neuroimmunol 74:85–94PubMed Clements JM, Cossins JA, Wells GMA, Corkill DJ, Helfrich K, Wood LM, Pigott R, Stabler G, Ward GA, Gearing AJH, Miller KM (1997). Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor. J Neuroimmunol 74:85–94PubMed
9.
go back to reference Cuzner ML, Opdenakker G (1999) Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol 94:1–14CrossRefPubMed Cuzner ML, Opdenakker G (1999) Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol 94:1–14CrossRefPubMed
10.
go back to reference DalCanto MC, Rabinowitz SG (1982) Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol 11:107–109PubMed DalCanto MC, Rabinowitz SG (1982) Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol 11:107–109PubMed
11.
go back to reference Dixon WJ (1993) BMDP statistical software manual, vol 1 and 2. University of California Press, Berkeley Dixon WJ (1993) BMDP statistical software manual, vol 1 and 2. University of California Press, Berkeley
12.
go back to reference Dubois B, Opdenakker G, Carton H (1999) Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neurol Belg 99:53–56PubMed Dubois B, Opdenakker G, Carton H (1999) Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neurol Belg 99:53–56PubMed
13.
go back to reference Gottschall PE, Deb S (1996) Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69–75PubMed Gottschall PE, Deb S (1996) Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69–75PubMed
14.
go back to reference Gottschall PE, Yu X (1995) Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64:1513–1520PubMed Gottschall PE, Yu X (1995) Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64:1513–1520PubMed
15.
go back to reference Graber HU, Müller CF, Vandevelde M, Zurbriggen A (1995) Retsricted infection with canine distemper virus leads to down-regulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol 90:312–318CrossRefPubMed Graber HU, Müller CF, Vandevelde M, Zurbriggen A (1995) Retsricted infection with canine distemper virus leads to down-regulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol 90:312–318CrossRefPubMed
16.
go back to reference Gröne A, Alldinger S, Baumgärtner W (2000) Interleukin-1β, -6, -12 and tumor necrosis factor-α expression in brains of dogs with canine distemper virus infection. J Neuroimmunol 110:20–30CrossRefPubMed Gröne A, Alldinger S, Baumgärtner W (2000) Interleukin-1β, -6, -12 and tumor necrosis factor-α expression in brains of dogs with canine distemper virus infection. J Neuroimmunol 110:20–30CrossRefPubMed
17.
go back to reference Hartung H-P, Kieseier, BC (2000) The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 107:140–147PubMed Hartung H-P, Kieseier, BC (2000) The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 107:140–147PubMed
18.
go back to reference Khuth S-T, Akaoka H, Pagenstecher A, Verlaeten O, Belin M-F, Giraudon P, Bernard A (2001) Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol 75:8268–8282CrossRefPubMed Khuth S-T, Akaoka H, Pagenstecher A, Verlaeten O, Belin M-F, Giraudon P, Bernard A (2001) Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol 75:8268–8282CrossRefPubMed
19.
go back to reference Kieseier BC, Paul R, Koedel U, Seifert T, Clements JM, Gearing AJ, Pfister HW, Hartung HP (1999) Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122:1579–1587CrossRefPubMed Kieseier BC, Paul R, Koedel U, Seifert T, Clements JM, Gearing AJ, Pfister HW, Hartung HP (1999) Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122:1579–1587CrossRefPubMed
20.
go back to reference Kieseier BC, Seifert T, Giovannoni G, Hartung H-P (1999) Matrix metalloproteinases in inflammatory demyelination—targets for treatment. Neurology 52:20–25 Kieseier BC, Seifert T, Giovannoni G, Hartung H-P (1999) Matrix metalloproteinases in inflammatory demyelination—targets for treatment. Neurology 52:20–25
21.
go back to reference Kouwenhoven M, Ozenci V, Gomes A, Yarilin D, Giedraitis V, Press R, Link H (2001) Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun 16:463–470CrossRefPubMed Kouwenhoven M, Ozenci V, Gomes A, Yarilin D, Giedraitis V, Press R, Link H (2001) Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun 16:463–470CrossRefPubMed
22.
go back to reference Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121:2327–2334CrossRefPubMed Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121:2327–2334CrossRefPubMed
23.
go back to reference Liedtke W, Cannella B, Mazzaccaro RJ, Clements JM, Miller KM, Wucherpfennig KW, Gearing AJ, Raine CS (1998) Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann Neurol 44:35–46PubMed Liedtke W, Cannella B, Mazzaccaro RJ, Clements JM, Miller KM, Wucherpfennig KW, Gearing AJ, Raine CS (1998) Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann Neurol 44:35–46PubMed
24.
go back to reference Lindberg RLP, De Groot CJA, Montagne L, Freitag P, Valk P van der, Kappos L, Leppert D (2001) The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124:1743–1753CrossRefPubMed Lindberg RLP, De Groot CJA, Montagne L, Freitag P, Valk P van der, Kappos L, Leppert D (2001) The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124:1743–1753CrossRefPubMed
25.
go back to reference Lo EH, Wang X, Cuzner ML (2002) Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69:1–9CrossRefPubMed Lo EH, Wang X, Cuzner ML (2002) Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69:1–9CrossRefPubMed
26.
go back to reference Markus S, Failing K, Baumgärtner W (2002) Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. J Neuroimmunol 125:30–41CrossRefPubMed Markus S, Failing K, Baumgärtner W (2002) Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. J Neuroimmunol 125:30–41CrossRefPubMed
27.
go back to reference Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125PubMed Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125PubMed
28.
go back to reference Matyszak MK, Perry VH (1996) Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases. J Neuroimmunol 69:141–149CrossRefPubMed Matyszak MK, Perry VH (1996) Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases. J Neuroimmunol 69:141–149CrossRefPubMed
29.
go back to reference McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13:534–540 McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13:534–540
30.
go back to reference Özenci V, Rinaldi L, Teleshova N, Matusevicius D, Kivisakk P, Kouwenhoven M, Link H (1999) Metalloproteinases and their tissue inhibitors in multiple sclerosis. J. Autoimmun 12:297–303CrossRef Özenci V, Rinaldi L, Teleshova N, Matusevicius D, Kivisakk P, Kouwenhoven M, Link H (1999) Metalloproteinases and their tissue inhibitors in multiple sclerosis. J. Autoimmun 12:297–303CrossRef
31.
go back to reference Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL (1998) Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729–741PubMed Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL (1998) Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729–741PubMed
32.
go back to reference Pringle CR (1999) Virus taxonomy at the Xith International Congress of Virology, Sydney, Australia. Arch Virol 144:2065–2070CrossRefPubMed Pringle CR (1999) Virus taxonomy at the Xith International Congress of Virology, Sydney, Australia. Arch Virol 144:2065–2070CrossRefPubMed
33.
go back to reference Ries C, Petrides PE (1995) Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 376:345–355 Ries C, Petrides PE (1995) Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 376:345–355
34.
go back to reference Rosenberg GA (2001) Matrix metalloproteinases in multiple sclerosis: Is it time for a treatment trial. Ann Neurol 50:431–433CrossRefPubMed Rosenberg GA (2001) Matrix metalloproteinases in multiple sclerosis: Is it time for a treatment trial. Ann Neurol 50:431–433CrossRefPubMed
35.
go back to reference Rosenberg GA (2001) Matrix metalloproteinases in multiple sclerosis: Is it time for a treatment trial. Ann Neurol 50:431–433Rosenberg GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39:279–291CrossRefPubMed Rosenberg GA (2001) Matrix metalloproteinases in multiple sclerosis: Is it time for a treatment trial. Ann Neurol 50:431–433Rosenberg GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39:279–291CrossRefPubMed
36.
go back to reference Rosenberg GA, Kornfeld M, Estrada E, Kelley RO Liotta LA, Stetler-Stevenson WG (1992) TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 576:203–207PubMed Rosenberg GA, Kornfeld M, Estrada E, Kelley RO Liotta LA, Stetler-Stevenson WG (1992) TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 576:203–207PubMed
37.
go back to reference Rosenberg GA, Cunningham LA, Wallace J (2001) Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893:104–112CrossRefPubMed Rosenberg GA, Cunningham LA, Wallace J (2001) Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893:104–112CrossRefPubMed
38.
go back to reference Sekine-Aizawa Y, Hama E, Watanabe K, Tsubuki S, Kanai-Azuma M, Kanai Y, Arai H, Aizawa H, Iwata N, Saido TC (2001) Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum. Eur J Neurosci 13:935–948CrossRefPubMed Sekine-Aizawa Y, Hama E, Watanabe K, Tsubuki S, Kanai-Azuma M, Kanai Y, Arai H, Aizawa H, Iwata N, Saido TC (2001) Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum. Eur J Neurosci 13:935–948CrossRefPubMed
39.
go back to reference Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374–17378PubMed Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374–17378PubMed
40.
go back to reference Streit WJ, Kreutzberg GW (1987) Lectin binding by resting and reactive microglia. J Neurocytol 16:249–260PubMed Streit WJ, Kreutzberg GW (1987) Lectin binding by resting and reactive microglia. J Neurocytol 16:249–260PubMed
41.
go back to reference Tipold A, Moore P, Zurbriggen A, Bürgener I, Barben G, Vandervelde M (1999) Early T cell response in the central nervous system in canine distemper virus infection. Acta Neuropathol 97:45–56CrossRefPubMed Tipold A, Moore P, Zurbriggen A, Bürgener I, Barben G, Vandervelde M (1999) Early T cell response in the central nervous system in canine distemper virus infection. Acta Neuropathol 97:45–56CrossRefPubMed
42.
go back to reference Wells GM, Catlin G, Cossins JA, Mangan M, Ward GA, Miller KM, Clements JM (1996) Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 18:332–340CrossRefPubMed Wells GM, Catlin G, Cossins JA, Mangan M, Ward GA, Miller KM, Clements JM (1996) Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 18:332–340CrossRefPubMed
43.
go back to reference Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2153PubMed Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2153PubMed
44.
go back to reference Wünschmann A, Alldinger S, Kremmer E, Baumgärtner W (1999) Identification of CD4+ and CD8+ T cell subsets and B cells in the brain of dogs with spontaneous acute, subacute- and chronic-demyelinating distemper encephalitis. J Vet Immunol Immunopathol 67:101–116CrossRef Wünschmann A, Alldinger S, Kremmer E, Baumgärtner W (1999) Identification of CD4+ and CD8+ T cell subsets and B cells in the brain of dogs with spontaneous acute, subacute- and chronic-demyelinating distemper encephalitis. J Vet Immunol Immunopathol 67:101–116CrossRef
45.
go back to reference Yong, VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75–80PubMed Yong, VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75–80PubMed
46.
go back to reference Zurbriggen A, Schmid I, Graber HU, Vandevelde M (1998) Oligodendroglial pathology in canine distemper. Acta Neuropathol 95:71–77CrossRefPubMed Zurbriggen A, Schmid I, Graber HU, Vandevelde M (1998) Oligodendroglial pathology in canine distemper. Acta Neuropathol 95:71–77CrossRefPubMed
Metadata
Title
Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis
Authors
Qin Miao
Wolfgang Baumgärtner
Klaus Failing
Susanne Alldinger
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 5/2003
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-003-0754-6

Other articles of this Issue 5/2003

Acta Neuropathologica 5/2003 Go to the issue